GRML (Greenland Mines) Notes Receivable: $0.00 Mil (As of Mar. 2026)


GRML Greenland Mines Ltd GRML
12 GF Score
Price $0.25
! 1 Warning Sign
View Full Analysis

What is Greenland Mines Notes Receivable?

Greenland Mines GRML +0.33% 12 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates GRML with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Greenland Mines's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Greenland Mines Notes Receivable Related Terms

Greenland Mines Notes Receivable Historical Data

* Premium members only.

The historical data trend for Greenland Mines's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenland Mines Notes Receivable Chart

Greenland Mines Annual Data
Trend
Notes Receivable

Greenland Mines Semi-Annual Data
Mar25 Mar26
Notes Receivable 0.00 0.00
GRML
12GF Score
Greenland Mines Ltd GRML
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenland Mines Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Greenland Mines (GRML) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Greenland Mines and its competitors.
Is Greenland Mines' Notes Receivable too high?
Greenland Mines' current Notes Receivable is $0.00 Mil. Overall, Greenland Mines has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Greenland Mines' Notes Receivable compare to SRGZ and RITE?
Greenland Mines' Notes Receivable of $0.00 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Metals & Mining company?
A good Notes Receivable depends on the Metals & Mining industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Greenland Mines and its competitors. Greenland Mines's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenland Mines stock overvalued right now?
Greenland Mines (GRML) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Greenland Mines' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Greenland Mines (GRML), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Greenland Mines Business Description

Address 1300 South Boulevard, Unit D, Charlotte, NC, USA, 28203
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
12GF Score

Get the complete analysis for GRML

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price